AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogen
- 13 January 2000
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 19 (2), 280-288
- https://doi.org/10.1038/sj.onc.1203303
Abstract
Transcription of the ERBB2 oncogene is repressed by oestrogen in human breast cancer cells. We show that a 218 bp fragment of the human ERBB2 gene promoter is responsive to oestrogen in transient transfection in ZR75.1 and SKBR.3 cells when the oestrogen receptor is expressed. Deletion analysis of this fragment shows that a sequence located at the 5′ end, which is known to mediate ERBB2 overexpression in breast cancer, is also responsible for the oestrogen response. This sequence binds AP-2 transcription factors and appears functionally identical to an element of the oestrogen-dependent enhancer described in the first intron of human ERBB2. We observed that oestrogen treatment down-regulates expression of AP-2 proteins but does not affect the DNA binding activity of AP-2. Constitutive expression of AP-2β or AP-2γ, but not AP-2α, abrogates the estrogenic repression. Our results demonstrate that AP-2 transcription factors are implicated in the oestrogenic regulation of ERBB2 gene expression and suggest a complex interplay involving the different AP-2 isoforms and other unidentified factors.Keywords
This publication has 31 references indexed in Scilit:
- A Synergistic Interaction of Transcription Factors AP2 and YB-1 Regulates Gelatinase A Enhancer-dependent TranscriptionPublished by Elsevier ,1998
- The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligandsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1998
- An intron 1 enhancer element mediates oestrogen-induced suppression of ERBB2 expressionOncogene, 1997
- AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expressionNature Genetics, 1997
- Mechanisms Identified in the Transcriptional Control of Epithelial Gene ExpressionJournal of Biological Chemistry, 1996
- N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation.Genes & Development, 1994
- ErbB‐2 expression in estrogen‐receptor‐positive breast‐tumor cells is regulated by growth‐modulatory reagentsInternational Journal of Cancer, 1994
- Tamoxifen up-regulates c-erbB-2 expression in oestrogen-responsive breast cancer cells in vitroEuropean Journal Of Cancer, 1992
- Base load fuel consumption with radiant boiler simulationIEEE Transactions on Energy Conversion, 1992
- Estrogen suppression of erbB2 expression is associated with increased growth rate of ZR‐75‐1 human breast cancer cells in vitro and in nude miceInternational Journal of Cancer, 1991